A citation-based method for searching scientific literature

Edward S Kim, Suanna S Bruinooge, Samantha Roberts, Gwynn Ison, Nancy U Lin, Lia Gore, Thomas S Uldrick, Stuart M Lichtman, Nancy Roach, Julia A Beaver, Rajeshwari Sridhara, Paul J Hesketh, Andrea M Denicoff, Elizabeth Garrett-Mayer, Eric Rubin, Pratik Multani, Tatiana M Prowell, Caroline Schenkel, Marina Kozak, Jeff Allen, Ellen Sigal, Richard L Schilsky. J Clin Oncol 2017
Times Cited: 228







List of co-cited articles
378 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working Group.
Stuart M Lichtman, R Donald Harvey, Marie-Anne Damiette Smit, Atiqur Rahman, Michael A Thompson, Nancy Roach, Caroline Schenkel, Suanna S Bruinooge, Patricia Cortazar, Dana Walker,[...]. J Clin Oncol 2017
89
24



Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Vivek H Murthy, Harlan M Krumholz, Cary P Gross. JAMA 2004
16

The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.
Joseph M Unger, Elise Cook, Eric Tai, Archie Bleyer. Am Soc Clin Oncol Educ Book 2016
223
12

Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations.
Arti Hurria, William Dale, Margaret Mooney, Julia H Rowland, Karla V Ballman, Harvey J Cohen, Hyman B Muss, Richard L Schilsky, Betty Ferrell, Martine Extermann,[...]. J Clin Oncol 2014
202
11

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Brain Metastases Working Group.
Nancy U Lin, Tatiana Prowell, Antoinette R Tan, Marina Kozak, Oliver Rosen, Laleh Amiri-Kordestani, Julia White, Joohee Sul, Louise Perkins, Katherine Beal,[...]. J Clin Oncol 2017
63
17

Participation of patients 65 years of age or older in cancer clinical trials.
Joy H Lewis, Meredith L Kilgore, Dana P Goldman, Edward L Trimble, Richard Kaplan, Michael J Montello, Michael G Housman, José J Escarce. J Clin Oncol 2003
758
11

Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.
Andrew L Laccetti, Sandi L Pruitt, Lei Xuan, Ethan A Halm, David E Gerber. J Natl Cancer Inst 2015
66
16


Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.
Joseph M Unger, Dawn L Hershman, Mark E Fleury, Riha Vaidya. JAMA Oncol 2019
64
15

Impact of prior cancer on eligibility for lung cancer clinical trials.
David E Gerber, Andrew L Laccetti, Lei Xuan, Ethan A Halm, Sandi L Pruitt. J Natl Cancer Inst 2014
74
13

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group.
Thomas S Uldrick, Gwynn Ison, Michelle A Rudek, Ariela Noy, Karl Schwartz, Suanna Bruinooge, Caroline Schenkel, Barry Miller, Kieron Dunleavy, Judy Wang,[...]. J Clin Oncol 2017
74
13

Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018.
Jonathan M Loree, Seerat Anand, Arvind Dasari, Joseph M Unger, Anirudh Gothwal, Lee M Ellis, Gauri Varadhachary, Scott Kopetz, Michael J Overman, Kanwal Raghav. JAMA Oncol 2019
136
10

Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement.
Arti Hurria, Laura A Levit, William Dale, Supriya G Mohile, Hyman B Muss, Louis Fehrenbacher, Allison Magnuson, Stuart M Lichtman, Suanna S Bruinooge, Enrique Soto-Perez-de-Celis,[...]. J Clin Oncol 2015
233
9

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
P N Lara, R Higdon, N Lim, K Kwan, M Tanaka, D H Lau, T Wun, J Welborn, F J Meyers, S Christensen,[...]. J Clin Oncol 2001
444
9


Factors Associated With Age Disparities Among Cancer Clinical Trial Participants.
Ethan B Ludmir, Walker Mainwaring, Timothy A Lin, Austin B Miller, Amit Jethanandani, Andres F Espinoza, Jacob J Mandel, Steven H Lin, Benjamin D Smith, Grace L Smith,[...]. JAMA Oncol 2019
84
10


Expanding the Evidence Base in Geriatric Oncology: Action Items From an FDA-ASCO Workshop.
Laura A Levit, Harpreet Singh, Heidi D Klepin, Arti Hurria. J Natl Cancer Inst 2018
44
15

Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review.
Jean G Ford, Mollie W Howerton, Gabriel Y Lai, Tiffany L Gary, Shari Bolen, M Chris Gibbons, Jon Tilburt, Charles Baffi, Teerath Peter Tanpitukpongse, Renee F Wilson,[...]. Cancer 2008
608
7

Underrepresentation of patients 65 years of age or older in cancer-treatment trials.
L F Hutchins, J M Unger, J J Crowley, C A Coltman, K S Albain. N Engl J Med 1999
7

Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018
7

Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working Group.
Lia Gore, S Percy Ivy, Frank M Balis, Eric Rubin, Katherine Thornton, Martha Donoghue, Samantha Roberts, Suanna Bruinooge, Jennifer Ersek, Nancy Goodman,[...]. J Clin Oncol 2017
51
13

Barriers to clinical trial participation by older women with breast cancer.
M Margaret Kemeny, Bercedis L Peterson, Alice B Kornblith, Hyman B Muss, Judith Wheeler, Ellis Levine, Nancy Bartlett, Gini Fleming, Harvey J Cohen. J Clin Oncol 2003
280
6


Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies.
Joseph M Unger, Dawn L Hershman, Raymond U Osarogiagbon, Anirudh Gothwal, Seerat Anand, Arvind Dasari, Michael Overman, Jonathan M Loree, Kanwal Raghav. JNCI Cancer Spectr 2020
22
27

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
6

Impact of prior cancer history on the overall survival of patients newly diagnosed with cancer: A pan-cancer analysis of the SEER database.
Huaqiang Zhou, Yan Huang, Zeting Qiu, Hongyun Zhao, Wenfeng Fang, Yunpeng Yang, Yuanyuan Zhao, Xue Hou, Yuxiang Ma, Shaodong Hong,[...]. Int J Cancer 2018
34
17

Enrollment of older adults on oncology trials: An FDA perspective.
Harpreet Singh, Julia A Beaver, Geoffrey Kim, Richard Pazdur. J Geriatr Oncol 2017
32
15

Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials.
Alice B Kornblith, Margaret Kemeny, Bercedis L Peterson, Judith Wheeler, Jeffrey Crawford, Nancy Bartlett, Gini Fleming, Stephen Graziano, Hyman Muss, Harvey Jay Cohen. Cancer 2002
137
5

A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
Sara H Javid, Joseph M Unger, Julie R Gralow, Carol M Moinpour, Antoinette J Wozniak, J Wendall Goodwin, Primo N Lara, Pamela A Williams, Laura F Hutchins, Carolyn C Gotay,[...]. Oncologist 2012
70
7

Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.
Carol A Townsley, Kelvin K Chan, Gregory R Pond, Christine Marquez, Lillian L Siu, Sharon E Straus. BMC Cancer 2006
94
5


Increasing Diversity in Clinical Trials: Overcoming Critical Barriers.
Luther T Clark, Laurence Watkins, Ileana L Piña, Mary Elmer, Ola Akinboboye, Millicent Gorham, Brenda Jamerson, Cassandra McCullough, Christine Pierre, Adam B Polis,[...]. Curr Probl Cardiol 2019
140
5

Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer.
Lauren M Hamel, Louis A Penner, Terrance L Albrecht, Elisabeth Heath, Clement K Gwede, Susan Eggly. Cancer Control 2016
163
5

Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.
David M Waterhouse, R Donald Harvey, Patricia Hurley, Laura A Levit, Edward S Kim, Heidi D Klepin, Kathryn Finch Mileham, Grzegorz Nowakowski, Caroline Schenkel, Courtney Davis,[...]. JCO Oncol Pract 2020
99
5

Addressing Financial Barriers to Patient Participation in Clinical Trials: ASCO Policy Statement.
Karen M Winkfield, Jonathan K Phillips, Steven Joffe, Michael T Halpern, Dana S Wollins, Beverly Moy. J Clin Oncol 2018
29
17

Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.
Blase N Polite, Lucile L Adams-Campbell, Otis W Brawley, Nina Bickell, John M Carethers, Christopher R Flowers, Margaret Foti, Scarlett Lin Gomez, Jennifer J Griggs, Christopher S Lathan,[...]. J Clin Oncol 2017
50
10

Overcoming Barriers to Clinical Trial Enrollment.
Ryan D Nipp, Kessely Hong, Electra D Paskett. Am Soc Clin Oncol Educ Book 2019
46
10

Older adult participation in cancer clinical trials: A systematic review of barriers and interventions.
Mina S Sedrak, Rachel A Freedman, Harvey J Cohen, Hyman B Muss, Aminah Jatoi, Heidi D Klepin, Tanya M Wildes, Jennifer G Le-Rademacher, Gretchen G Kimmick, William P Tew,[...]. CA Cancer J Clin 2021
58
8


Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study.
Arti Hurria, Kayo Togawa, Supriya G Mohile, Cynthia Owusu, Heidi D Klepin, Cary P Gross, Stuart M Lichtman, Ajeet Gajra, Smita Bhatia, Vani Katheria,[...]. J Clin Oncol 2011
4

Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer.
Arti Hurria, Supriya Mohile, Ajeet Gajra, Heidi Klepin, Hyman Muss, Andrew Chapman, Tao Feng, David Smith, Can-Lan Sun, Nienke De Glas,[...]. J Clin Oncol 2016
323
4

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.
Joan L Warren, Carrie N Klabunde, Deborah Schrag, Peter B Bach, Gerald F Riley. Med Care 2002
4


Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.
Matthew T Seymour, Lindsay C Thompson, Harpreet S Wasan, Gary Middleton, Alison E Brewster, Stephen F Shepherd, M Sinead O'Mahony, Timothy S Maughan, Mahesh Parmar, Ruth E Langley. Lancet 2011
236
4

Cancer treatment and survivorship statistics, 2016.
Kimberly D Miller, Rebecca L Siegel, Chun Chieh Lin, Angela B Mariotto, Joan L Kramer, Julia H Rowland, Kevin D Stein, Rick Alteri, Ahmedin Jemal. CA Cancer J Clin 2016
4

Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer.
Sandi L Pruitt, Andrew L Laccetti, Lei Xuan, Ethan A Halm, David E Gerber. Br J Cancer 2017
33
12

Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes.
Jatin J Shah, Rafat Abonour, Christina Gasparetto, James W Hardin, Kathleen Toomey, Mohit Narang, Shankar Srinivasan, Amani Kitali, Faiza Zafar, E Dawn Flick,[...]. Clin Lymphoma Myeloma Leuk 2017
48
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.